Monday, November 24, 2014 12:23 AM
NEW YORK—On Nov. 20,
Valeant Pharmaceuticals International Inc.
cut its stake in
to 0.1 percent, according to a filing with the Securities and Exchange Commission (SEC). At that time, Pershing Square Capital Management informed Valeant that “PS Fund 1 sold all of the 2,242,560 shares of Common Stock allocated to Valeant USA,” according to the regulatory filing.
Friday, November 21, 2014 12:26 AM
Valeant Pharmaceuticals International, Inc.
(NYSE: VRX) (TSX: VRX) announced that its board of directors has authorized a new securities repurchase program (the "Securities Repurchase Program").
Monday, November 17, 2014 9:30 AM
DUBLIN, Ireland and IRVINE, Calif.—
(NYSE: ACT) and
(NYSE: AGN) today announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock.
Wednesday, November 12, 2014 12:23 AM
InSite Vision Incorporated
(OTCBB: INSV) reported financial results for the quarter ended Sept. 30, 2014. Revenues for the third quarter of 2014 were $0.4 million compared to $5.3 million for the same period in 2013.
Monday, November 10, 2014 12:26 AM
New Look Eyewear Inc.
(BCI) has announced its third quarter results for 2014, reporting revenues of $32.5 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $6.2 million for the third quarter ended Sept. 27, 2014.
Monday, November 10, 2014 12:23 AM
REDWOOD CITY, Calif.—
, a developer of wearable near eye displays based here, announced that they have raised $9.37 million in a Series A funding.
Friday, November 07, 2014 12:26 AM
PADUA, Italy—The Board of Directors of
Safilo Group S.p.A.
(SFLG.MI), has approved the results of the third quarter and first nine months of 2014, ended Sept. 30, 2014.
Friday, November 07, 2014 12:23 AM
(OTCBB: XSPY) has announced the financial results for the third quarter and nine months ended Sept. 30, 2014.
Friday, October 31, 2014 12:23 AM
(NYSE: LUX) reported strong sales in its wholesale and retail sectors for the third fiscal quarter, ending Sept. 30.
Friday, October 31, 2014 12:20 AM
(TOKYO: 7741) reported a significant upturn in revenue and profit for the second quarter ended Sept. 30, 2014. During the quarter, revenues totaled 121,242 million yen, increasing by 18.6 percent from the same period the previous year.
Wednesday, October 29, 2014 4:05 PM
MILAN—Against the backdrop of a strong third fiscal quarter, which saw increases in the company’s retail and wholesale division, worldwide,
said its board of directors, today, upon the chairman Leonardo Del Vecchio’s recent proposal, entrusted Massimo Vian, on an interim basis, with all executive responsibilities until Adil Mehboob-Khan joins Luxottica as co-CEO.
Wednesday, October 29, 2014 12:23 AM
(NVS: NYSE) delivered solid sales growth with strong margin expansion and major innovation in the third quarter ended Sept. 30, 2014.
Wednesday, October 29, 2014 12:14 AM
IRVINE, Calif.—With net sales of $1,790.7 million for the third quarter ended Sept. 30, 2014, a 17.2 percent increase over net sales for the third quarter of 2013,
(NYSE: AGN) reported its “strongest increase in absolute dollar sales in any quarter in our history,” according to David E.I. Pyott, chairman and CEO, in a statement released by Allergan on Monday, Oct. 27, 2014.
Monday, October 27, 2014 12:23 AM
(Reuters: ESSI.PA) announced Friday that consolidated revenue for the third quarter of 2014, ending Sept. 30, climbed to €1,415 million, an increase of 14.5 percent, excluding the currency effect, over third quarter 2013.
Wednesday, October 22, 2014 12:23 AM
LAVAL, Quebec—Valeant Pharmaceuticals, Inc. (NYSE/TSX: VRX) reported its total revenue for the third fiscal quarter ended Sept. 30, 2014, was $2.1 billion, up 33 percent compared to the third quarter of 2014, with the U.S. and emerging market businesses contributing strong double-digit, same-store organic growth.